Buerger's Disease Market is driven by regenerative therapies
The Buerger’s Disease Market encompasses a range of therapeutic solutions designed to treat thromboangiitis obliterans, a non-atherosclerotic vascular disorder primarily affecting small- and medium-sized arteries and veins. Leading product categories include vasodilators, prostaglandin analogues, antiplatelet agents, and emerging regenerative options such as stem cell–based...
0 Commentarii 0 Distribuiri 147 Views 0 previzualizare